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RESUMO
Introdução / Objetivo: Este estudo é determinar essas manifestações de pacientes com HIV / AIDS em Ilorin para atualizar no estudo
anterior.
Método: Este foi um estudo prospectivo de todos os pacientes consecutivos novo confirmado para ser HIV positivo
atendidos na clínica de HIV da Universidade de Ilorin Hospital, Ilorin, no estado de Kwara, na Nigéria, entre
janeiro e julho de 2009. These estavam em anti HAART tratamento de drogas retrovirais. As informações
recuperadas incluído o de dados biográficos, apresentação clínica, otorrinolaringológicas achados clínicos, bem
como a sua avaliação da audição com audiometria tonal.
Resultados: 74 fora dos 89 pacientes HIV (82,8 %) apresentaram manifestações otorrinolaringológicas com a faixa etária
de 3 a 62 anos (média de 36.4 anos, DP = 2,45 ± 0,02). A faixa etária modal era de 21 40 anos (59,6%) 51
masculinos. (57,3 %) e 38females (42,7 %) e razão sexual de 1,3:1. Apresenta os mais comuns otorrinolaringológico
incluíram nasal em 45,6% (rinossinusite crônica), adenopatia oral / orofaringe em 23,9% (candidíase oral),
otológica em 21,5% (otite média serosa) e cervical em 9%.
Conclusão: As manifestações otorrinolaringológicas foram encontrados em 74 pacientes (82,8%) e as características comuns
sinusite crônica, oral / candidíase faringe, otite média serosa com adeopathy cervical , nessa ordem. É importante
para os otorrinos estar ciente das manifestações otorrinolaringológicas, assim que o diagnóstico precoce e
intervenção atempada junto com terapia anti- retroviral adequado ser instituído para melhorar as taxas de
sobrevivência
Palavras-chave: sinusite, otite média com efusão, candidíase bucal, HIV.
SUMMARY
Introduction/Aim: This study is to determine these manifestations among HIV/AIDS patients in Ilorin to update on previous study.
Method: This was a prospective study of all consecutive new patients confirmed to be HIV positive attending the HIV
clinic of the University of Ilorin Teaching Hospital, Ilorin, Kwara state, Nigeria between January and July, 2009.
These patients were on HAART anti retroviral drug treatment. The information retrieved included the biodata,
clinical presentation, otolaryngologic clinical findings, as well as their hearing assessment with Pure tone audiometry.
Results: 74 out of the 89 HIV patients(82.8%) had otorhinolaryngological manifestations with the age range of 3 to 62
years (Mean of 36.4 yrs, SD=2.45±0.02). The modal age range was 21-40 years (59.6%) 51males (57.3%) and
38 females (42.7%) and a sex ratio of 1.3:1. Commonest otorhinolaryngological features included nasal in 45.6%
(chronic rhinosinusitis), oral/oropharyngeal in 23.9% (oral candidiasis), otological in 21.5% (Serous otitis media)
and cervical adenopathy in 9%.
Conclusion: Otorhinolaryngological manifestations were found in 74 patients (82.8%) and commonest features included
chronic sinusitis, oral/pharyngeal candidiasis, serous otitis media with cervical adeopathy in that order. It is
important for otolaryngologists to be aware of otolaryngological manifestations, so early diagnosis and timely
intervention alongside appropriate anti-retroviral therapy be instituted to improve survival rates.
Keywords: sinusitis, otitis media with effusion, candidiasis oral, HIV.
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INTRODUCTION
HIV infection is a global pandemic, with an estimated
42 million among adults worldwide, two thirds of who are
in sub-Saharan Africa; 47% of cases are women and an
estimated 1.3 million children less than 15 years of age (1).
The reported prevalence of ENT, head and neck
manifestations of HIV/AIDS worldwide varies from 41 to
80% (2,3,4,5).
In the United States, HIV sero-prevalence varied
between 0.45% - 27.5% while it is 1.2% - 12% in Nigeria (6,
7). HIV preferentially infects cells of the nervous and
lymphatic systems. The most important cell infected is the
T-helper cell, through the CD4 receptor, resulting in both
functional impairment and numeric depletion of T helper
cells. The transmission of the virus occurs through blood
and its products, sexual contacts, transplacentally in utero
and via breast feeding (8).
The causes of ORL manifestations are due to
infections, neoplasms and primary neurological damage
resulting from the HIV (9).
This study is to reappraise these features among
HIV/AIDS patients after a preliminary study done among
29 patients at our centre over five years ago (10).
METHOD
This was a prospective study of all consecutive new
patients confirmed to be HIV positive using the ELISA
technique with confirmation by the Western blot assays
attending the HIV clinic of the University of Ilorin Teaching
Hospital, Ilorin, Kwara state, Nigeria between January and
July, 2009. These patients were on HAART anti retroviral
drug treatment.
Informed consents from individual patient and ethical
approvals were obtained from the hospital authority. The
information retrieved included the biodata, clinical
presentation, otolaryngologic clinical findings, as well as
their hearing assessment with Pure tone audiometry (using
clinical diagnostic audiometer Madsen OB 822, Denmark
calibrated according to ISI). Patients with inadequate records
were excluded from analysis. Data were entered into the
computers and analysed with EPI INFO 2005 version 3.
RESULTS
A total of 100 patients were seen over the study
period but 89 patients had complete data for analysis.
There were 51 males (57.3%) and 38 females (42.7%) with
a sex ratio of 1.3:1. The age range was 3 to 62 years (Mean
of 36.4 yrs, SD=2.45±0.02). The modal age range was 21-
40years (59.6%), followed by 41 to 60(36%) and over sixty
and below twenty years were 2 (2.2%) each (Table 1).
Majority of the patients 44 (49.4%) were self
employed, 14 (15.6%) were unemployed, 12 (13.5%)
were civil servants and artisans, 3 (3.4%) were security
forces and 2 (2.3%) each were either farmers or pensioners
(Table 2). Seventy-six (85.4%) of the respondents were
married while 8 (9%) were single, 4 (4.5%) were widowed
and only one (1.1%) was divorced. History of smoking was
found only among 18% of the respondent while 73 (82%)
do not smoke and 19 (21.3%) take alcohol.
The risk factors for HIV transmission included hetero-
sexual contacts in 90% of cases, blood transfusions in 5%
and others were 5%. The average period between diagnosis
and commencement of anti-retroviral drugs is 3 to 6
months.
Relating to otorhinological symptoms, otological
symptoms included 9 (10.1%) with hearing loss, 14 (15.7%)
cases of tinnitus and vertigo each, 12 (13.5%) with ear
blockage and 13 (14.6%) with otalgia (Table 3).
Pharyngeal symptoms included 40 (44.9%) with
oral/oropharyngeal candidiasis, 18 (20.2%) with recurrent
aphthous ulcers and 11 (12.4%) with dysphagia and
odynophagia.
Table 1. Age disribution of HIV patients
Age range Frequency Percentage (%)
>20yrs 2 2.2
21-39yrs 53 59.6
40-64yrs 34 38.2
> 65yrs 0 0
Total 89 100
Table 2. Occupational distribution among HIV/AIDS patients.
Occupation Frequency Percentage (%)
Civil servant 12 13.5
Artisan 12 13.5
Farming 2 2.3
Self employed 44 49.4
Unemployed 14 15.6
Security/force 3 3.4
Pensioner 2 2.3
Total 89 100
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Nasal symptoms included nasal blockage in 19
(24.3%), 10 (11.2%) had history of epistaxis, 25 (30.3%)
with anosmia, 58 (65.2%) had recurrent nasal discharge
(catarrh) (65.8%), 30 (33.7%) had recurrent sneezing, 4
(4.5%) with snoring (Table 3). Cervical swellings occured
in 30 (33.7%) patients, other constitutional symptoms
occurred in 42 patients.
The duration of diagnosis ranged from 1week to 13
yrs with the modal duration of less than 2 yrs. 68 (76.4%)
of the respondents have commenced antiretroviral drugs
which ranged from less than 3 months to over 12 months.
Ear examination revealed 11 had wax impaction in either
of the ears, 1 (1.1%) with otomycosis, one with chronic
suppurative otitis media, but evidence of serous otitis
media (glue ear) in 58 (65.1%) but there was no evidence
of Ramsay-Hunt syndrome.
Pure tone audiometry showed conductive hearing
loss (CHL) in 20 (22.5%) on the right and 30 (33.7%) on the
left ears, sensori-neural (SNHL) in 9 (10.1%) on the right,
7 (7.9%) on the left, mixed hearing loss 8 (9%) on the right,
7 (7.9%) on the left (Table 4). Categorization of degree of
hearing showed normal hearing in 15 (16.9%) on the right,
11 (12.4%) on the left, mild hearing loss in 22 (24.7%) on
the right, 24 (27%) on the left, moderate hearing loss in 32
(36%) on the right, 38 (42.7%) on the left, moderately-
severe hearing in 19 (21.3%) on the right, 16 (18%) on the
left, severe hearing loss only in 1 (1.1%) right ear. The nasal
examination revealed engorged inferior turbinates on an-
terior rhinoscopy in 82 (92.1%) of the patients,
oropharyngeal examination revealed amputated uvula in
14 (15.7%), hypertrophied and atrophied tonsils in 3
(3.4%) and 9 (10.1%) patients respectively. There was
evidence of chronic pharyngitis (granular posterior
pharyngeal wall) in 74 (83.1%), hyperaemia in 4 (4.5%)
and normal in 11 (12.4%) patients.
DISCUSSION
Since the infective agent responsible for HIV/AIDS
was discovered in 1983, the spectrum of manifestations
has become well defined with nearly 84% of infected
individuals having otorhinolaryngological symptoms or
signs (11). Various studies reported varied prevalences,
MARUSANN and SOY (6), in their study of 399 patients with
AIDS, found that 165 (41%) had symptoms related to
otolaryngology. WILLIAMS (12), in his study of 50 patients
with diagnosis of pediatric AIDS, reported otolaryngological
manifestation to occur in more than 80% of patients.
CHANDRA PRASAD et al reported a prevalence of 79% among
968 patients with HIV (13), earlier report by ALABI et al in
Ilorin, Nigeria (2004) reported a prevalence of 78% among
29 patients (10).
Although the ENT manifestations in this population
(82.8%) are certainly higher than in the general population,
not all of them could be solely attributed to the HIV sero-
positiveness. It is known that HIV infections are generally
symptomless and once AIDS is established this figure
changes dramatically.
The modal age of between 21-39 yr which differ
from other studies with age range 20-49 yrs (14) still fall
Table 3 A. Otorhinolaryngological manifestaions among
HIV/AIDS patients : Symptoms
Symptoms Frequency
Otological
Hearing loss  9 (10.1%)
Tinnitus 14 (15.7%)
Vertigo 14 (15.7%)
Ear blockage 12 (13.5%)
Otalgia 13 (14.6%)
Otitis Externa 3 (3.4%)
Hearing impairment 6 (6.7%)
Total 71
Nasal
Nasal blockage 19 (21.3%)
Epistaxis (Nose bleeds) 10 (11.4%)
Recurrent nasal discharge 58 (65.2%)
Sneezing 35 (39.3%)
Anosmia 25 (30.3%)
Snoring 4 (4.5%)
Total 151
Table 3B
Oral /Oropharyngeal
Recurrent aphthous ulcers  28 (20.2%)
Dysphagia/odynophagia 11 (12.4%)
Oral candidiasis 40 (44.9%)
Total 79
Neck(Cervical) Swellings 30 (33.7%)
Other constitutional symptoms 42 (47.2%)
Cough/weight loss/anorexia/diarrhoea
Table 4. Pure tone audiometric outcome among HIV patients.
Frequency Frequency
Right Left
Conductive hearing loss(CHL) 24 (27%) 33 (37.1%)
Mixed hearing loss 8 (9.0%) 7 (7.9%)
Sensori-neural hearing loss(CHL) 13 (14.6%) 11 (12.4%)
Normal hearing 15 (16.9%) 11 (12.4%)
Total 89 (100%)
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within age group found by most studies; however our
study found a lower value compared to somefun et al in
Nigeria and a lower age group of 3 yrs which was limited
to few studies (15, 16). Our study showed a higher
prevalence among the males compared to the females
which is similar to most studies in different part of the world
(3-6, 17, 18).
Majority of the patients were self employed in
49.4% most of whom are involved in trading and small scale
business followed by unemployed ,this indicated that HIV
is still most prevalent among the lower socio-economic
class similar to a study in some parts of Africa (14).
The study showed that more than three-quarter of
the respondents were married but this does not indicate
the source of the infection with the least among the
divorcee, most studies does not highlight the marital status
of the respondents. Incidence of alcohol ingestion and
smoking have been found to be very low among the
respondents which most literatures are silent about as it is
not a high risk and majority of those involved in the habit
of either smoking or alcohol consumptions have been
doing so for between 6 months to 20 yrs duration.
Chronic rhinosinusitis was found to be the
commonest manifestation in our series ,evidenced by
clinical presentation of recurrent nasal discharge and
obstruction, sneezing,epistaxis, supported by the
examination findings of engorged turbinate which is similar
to findings in other part of the world (11,12,19,20).
Rhinosinusitis is common in HIV-infected patients, with a
reported prevalence between 20% and 68% (21). The
reasons adduced included changes in the mucociliary
clearance, a primary local defense mechanism for the
sinuses. The bacteriology of acute sinusitis in this population
includes the same organisms normally considered in the
immunocompetent patient however, In late stages of HIV
infection, atypical opportunistic fungal sinusitis is the rule.
Oral and oropharyngeal symptoms were the second
commonest in our study with oral candidiasis and recurrent
sore throat with aphthous ulcers being the commonest
oropharyngeal symptoms , this is similar to studies in other
part of the world that found oropharyngeal candidiasis to
be the commonest presentations (18, 22).
The commonest otological symptoms were tinnitus
and vertigo in 15.7% each followed by otalgia and ear
blockage in 14.6% and 13.5% respectively, the least was
hearing loss of which serous otitis media was the commonest.
The most common otologic problems reported in HIV-
infected patients are serous otitis media due usually to
eustachian tube dysfunction and recurrent acute otitis
media (23).
Eustachian tube dysfunction can result from
nasopharyngeal lymphoid hyperplasia, sinusitis,
nasopharyngeal neoplasms, or allergies and their associated
mucosal changes. This is at variance with study in other part
of the world that reported sudden sensorineural hearing
loss, chronic and recurrent otitis media to be the commonest
otological manifestation (17, 18, 19), tympanic membrane
perforation in only one of the respondent this is an unusual
finding compared to other studies where chronic otitis
media was one of the commonest ENT findings and may
also be a hallmark in some reports (13, 17). Audiological
evaluations showed conductive hearing loss in 27-37% of
the respondents, sensorineural in 12-14.6% while normal
hearing was found only among 12-17% of the respondents
this was at variance with study done by somefun et al who
found sensorineural hearing loss to be the commonest (5)
although the pure tone audiometry is a subjective test but
it has been supported by earlier clinical findings.
Other studies elsewhere have reported that most
otological problems are caused by routine organisms that
respond to standard therapy (4) or may be as a result of
direct consequence of virus or secondary to the
pharmacological treatment (21). The cause of the hearing
loss cannot be substantiated by our study as the hearing
assessment was not done before the commencement of
the anti-retroviral drugs which is an area of challenge to
focus in future studies to compare the hearing assessment
before and after commencement of anti-retroviral
therapies.
Due to the involvement of central nervous system
in HIV infection, the most direct consequence to the
auditory system is central auditory nervous system
abnormalities similar extrapolation can be drawn to the
effect on the olfactory nerve of smell as it affects almost
one-third of the respondents (24). Cervical adenopathy
was the fourth commonest, however other studies have
found cervical manifestation to be the most frequent
symptoms of presentation (25-29). There was no either
Kaposi sarcoma or non Hodgkin’s lymphoma in our series
as compared to study in the developed world
CONCLUSION
In conclusion, ENT manifestation of HIV occurred in
over four-fifth of the patients with leading features of
chronic rhinosinusitis,oropharyngeal candidiasis,serous otitis
media and cervical adenopathy.Often, the otolaryngologist
is the primary physician who diagnoses the HIV infection.
He should be aware and vigilant for its symptoms and
unusual presentations. With more people coming forward
for voluntary counselling and testing for HIV,it is important
for otolaryngologists to be aware of otolaryngological
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manifestations so early diagnosis and timely intervention
alongside appropriate anti-retroviral therapy be instituted
to improve survival rates.
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